MDAI Spectral AI Inc

Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that management is scheduled to participate in the following investor conferences:

• KeyBanc Capital Markets Emerging Technology SummitWednesday, March 6, 2024Fireside Chat at 2:00 pm ET / 11:00 am PTSan Francisco, CA

• 36th Annual ROTH ConferenceMonday, March 18 and Tuesday, March 19, 2024Dana Point, CA

• KeyBanc Capital Markets Life Sciences & MedTech Investor Forum Wednesday, March 20, 2024Fireside Chat at 3:45 pm ET / 12:45 pm PTVirtual

Management will be hosting 1x1 meetings during these conferences. Interested parties may access live and archived webcasts of these events by visiting the Investors section of Spectral AI’s website at https://investors.spectral-ai.com/news-events/events.

About Spectral AISpectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of substantially exceeding the current standard of care in the future, DeepView® is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView®, visit www.spectral-ai.com.

Forward Looking StatementsCertain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.

Contacts
Investors
Equity Group
Devin SullivanManaging Directordsullivan@equityny.com	Conor RodriguezAnalystcrodriguez@equityny.com
Media
Russo Partners
David Schull(858) 717-2310david.schull@russopartnersllc.com